Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
7d agoen
From the article
Conditions : Anal Squamous Cell Carcinoma Interventions : Drug: Lenvatinib; Drug: Pembrolizumab Sponsors : University of Texas Southwestern Medical Center; Merck Sharp & Dohme LLC Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·1d ago
ClinicalKey
clinicalkey.com·1mo ago
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
doi.org·6d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
New cancer drug trial offers hope for patients with rare aggressive tumour
Reading Chronicle·1d ago
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer | NEJM
nejm.org·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.